[1]
W. Daniszewski, “Systemic Effects of Phosphodiesterase Type 5 Inhibitors Beyond Erectile Dysfunction: A Narrative Review”, Jour.Innov.Trend.Soc.Scie, vol. 2, no. 2, pp. 87–100, Dec. 2025.